Epidiolex

Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
Clinical Trials Arena
Fri, 08/23/24 - 10:47 am
Jazz Pharma
Cannabidiol
Japan
Epidiolex
Jazz sues generics makers for infringement on cannabis-derived epilepsy drug
Fierce Pharma
Thu, 01/5/23 - 05:00 pm
Jazz Pharma
legal
cannabindoids
Epidiolex
generics
patents
PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex
Fierce Pharma
Fri, 12/2/22 - 11:07 am
PureTech Health
Jazz Pharma
Epidiolex
Cannabidiol
Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial
BioSpace
Thu, 08/18/22 - 12:45 pm
Jazz Pharma
Epidiolex
clinical trials
pediatrics
epilepsy
cannabindoids
Trial failure for Jazz’s cannabis-derived drug blunts goal to expand its use to US
Fierce Pharma
Tue, 06/28/22 - 10:55 am
Jazz Pharma
cannabinoids
Epidiolex
GW Pharma
UCB takes on Jazz in severe epilepsy with new Fintepla approval
Pharmaforum
Mon, 03/28/22 - 10:06 am
UCB Pharma
FDA
Fintepla
Lennox-Gastaut Syndrome
Jazz Pharma
Epidiolex
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Stat
Wed, 02/3/21 - 10:58 am
Jazz Pharma
GW Pharma
M&A
CBD
epilepsy
Epidiolex
GW Pharmaceuticals' Epidiolex Wins New FDA Approvals
Motley Fool
Mon, 08/3/20 - 11:33 pm
GW Pharma
Cannabidiol
Epidiolex
FDA
tuberous sclerosis complex
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Sat, 07/25/20 - 02:25 pm
FDA
GW Pharma
Epidiolex
filgotinib
Galapagos
Biomarin
valoctocogene roxaparvovec
How GW Pharmaceuticals Hit a Home Run in Q1
Motley Fool
Tue, 05/12/20 - 11:48 am
GW Pharma
earnings
Epidiolex
Zogenix's Positive Clinical Trial Wasn't Positive Enough
Motley Fool
Sun, 02/9/20 - 04:08 pm
Zogenix
epilepsy
Lennox-Gastaut Syndrome
clinical trials
Fintepla
GW Pharma
Epidiolex
GW's Epidiolex topped sales predictions, but investors bailed. What gives?
Fierce Pharma
Thu, 11/7/19 - 10:13 am
GW Pharma
Epidiolex
GW Pharma's cannabis-derived epilepsy medicine makes the cut in the European Union
Endpoints
Tue, 09/24/19 - 10:59 am
GW Pharma
Europe
Epidyolex
Epidiolex
5 Things You'll Want to Watch With GW Pharmaceuticals
Motley Fool
Wed, 06/12/19 - 09:41 am
GW Pharma
Epidiolex
Europe
Sativex
regulatory
GW Pharma scores another PhIII win for its cannabinoid in rare form of epilepsy
Endpoints
Mon, 05/6/19 - 07:35 pm
GW Pharma
clinical trials
Epidiolex
cannabindoids
tuberous sclerosis complex
Early Epidiolex sales push up GW Pharma's stock
BioPharma Dive
Wed, 02/27/19 - 10:04 pm
Epidiolex
GW Pharma
epilepsy
Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It?
Motley Fool
Tue, 11/27/18 - 11:27 pm
GW Pharma
Epidiolex
Cannabidiol
clinical trials
Dravet syndrome
Why GW Pharmaceuticals Stock Jumped 17.7% in September
Moltey Fool
Sat, 10/6/18 - 12:46 pm
GW Pharma
Epidiolex
GW Pharma looks to dispel cannabis stigma with Epidiolex launch
Fierce Pharma
Fri, 10/5/18 - 08:53 pm
GW Pharma
Epidiolex
drug launches
Cannabidiol
Cannabis-Based Drug Companies Hopeful Epidiolex Will Pave the Way for Future Approvals
BioSpace
Tue, 10/2/18 - 10:47 pm
GW Pharma
FDA
Epidiolex
cannabindoids

Pages